,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,421,1,3,,17389556,21013,Inconclusive,,,,,Cell Viability - BJ,Confirmatory,,
1,426,1,2,,17389556,21013,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
2,427,1,1,,17389556,21013,Inconclusive,,,,,Cell Viability - Hek293,Confirmatory,,
3,433,1,1,,17389556,21013,Active,,,,,Cell Viability - HepG2,Confirmatory,,
4,434,1,2,,17389556,21013,Inconclusive,,,,,Cell Viability - MRC5,Confirmatory,,
5,435,1,2,,17389556,21013,Inconclusive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
6,445,3,1,,17389556,21013,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
7,530,1,1,,17389556,21013,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
8,540,1,1,,17389556,21013,Active,,,,,Cell Viability - N2a,Confirmatory,,
9,541,1,1,,17389556,21013,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
10,542,1,1,,17389556,21013,Inconclusive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
11,543,1,1,,17389556,21013,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
12,544,2,1,,17389556,21013,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
13,545,1,1,,17389556,21013,Inconclusive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
14,546,1,1,,17389556,21013,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
15,584,1,3,,17389556,21013,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
16,585,1,4,,17389556,21013,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
17,595,1,3,,17389556,21013,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
18,596,1,2,,17389556,21013,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
19,603,1,2,,17389556,21013,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
20,605,1,2,,17389556,21013,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
21,654,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
22,655,1,1,,17389556,21013,Active,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
23,656,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
24,657,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
25,658,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
26,659,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
27,660,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
28,661,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
29,662,1,1,,17389556,21013,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
30,663,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
31,664,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
32,665,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
33,666,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
34,667,1,1,,17389556,21013,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
35,875,1,2,,17389556,21013,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
36,880,2,1,,17389556,21013,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
37,880,2,1,,17389556,21013,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
38,881,2,2,,17389556,21013,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
39,884,1,2,,17389556,21013,Inconclusive,13435386.0,1576.0,12.5893,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
40,885,1,2,,17389556,21013,Inactive,13435386.0,1576.0,12.5893,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
41,886,1,2,,17389556,21013,Active,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
42,886,1,2,,17389556,21013,Active,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
43,887,1,2,,17389556,21013,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
44,889,1,3,,17389556,21013,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
45,892,1,2,,17389556,21013,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
46,893,1,2,,17389556,21013,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
47,893,1,2,,17389556,21013,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
48,894,2,1,,17389556,21013,Inconclusive,31542939.0,3248.0,11.2202,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
49,900,1,3,,17389556,21013,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
50,902,1,2,,17389556,21013,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
51,912,1,2,,17389556,21013,Active,21392848.0,,7.9433,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
52,921,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
53,923,1,2,,17389556,21013,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
54,924,1,2,,17389556,21013,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
55,925,1,2,,17389556,21013,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
56,926,1,2,,17389556,21013,Inconclusive,38016895.0,7253.0,39.8107,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
57,938,1,2,,17389556,21013,Active,38016895.0,7253.0,39.8107,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
58,946,1,2,,17389556,21013,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
59,947,1,2,,17389556,21013,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
60,948,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
61,955,1,2,,17389556,21013,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
62,960,1,2,,17389556,21013,Inconclusive,,,39.8107,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
63,961,1,2,,17389556,21013,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
64,962,1,2,,17389556,21013,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
65,963,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
66,964,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
67,965,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
68,966,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
69,967,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
70,968,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-009,Confirmatory,,
71,969,1,2,,17389556,21013,Inconclusive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
72,970,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-013,Confirmatory,,
73,971,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
74,972,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-017,Confirmatory,,
75,973,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
76,974,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-021,Confirmatory,,
77,975,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
78,976,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
79,977,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
80,978,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
81,979,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
82,980,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
83,981,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
84,982,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-012,Confirmatory,,
85,983,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
86,984,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
87,985,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
88,986,1,2,,17389556,21013,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-020,Confirmatory,,
89,987,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
90,988,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
91,989,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
92,993,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
93,994,1,2,,17389556,21013,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
94,995,1,2,,17389556,21013,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
95,1030,2,1,,17389556,21013,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
96,1188,1,2,,48415412,21013,Active,,,,,DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity,Other,,
97,1452,1,1,,17389556,21013,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
98,1457,1,1,,17389556,21013,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
99,1458,1,1,,17389556,21013,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
100,1469,1,1,,17389556,21013,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
101,1471,2,1,,17389556,21013,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
102,1476,2,1,,17389556,21013,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
103,1477,1,1,,17389556,21013,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
104,1478,2,1,,17389556,21013,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
105,1479,1,2,,17389556,21013,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
106,1948,1,1,,17389556,21013,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
107,2101,1,1,,17389556,21013,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
108,2107,1,1,,17389556,21013,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
109,2112,1,1,,17389556,21013,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
110,2120,1,1,,17389556,21013,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
111,2517,2,1,,17389556,21013,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
112,2546,1,1,,17389556,21013,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
113,2549,1,1,,17389556,21013,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
114,2551,1,1,,17389556,21013,Inconclusive,188536040.0,19885.0,35.4813,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
115,485290,1,1,,17389556,21013,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
116,488839,1,1,,85148639,21013,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
117,488839,1,1,,85148639,21013,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
118,488862,1,1,,85148639,21013,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
119,488895,1,2,,85148639,21013,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
120,488896,1,1,,85148639,21013,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
121,488899,1,1,,85148639,21013,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
122,488965,1,2,,85148639,21013,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
123,488966,1,1,,85148639,21013,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
124,492953,1,1,,85148639,21013,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
125,492956,1,1,,85148639,21013,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
126,492972,1,1,,85148639,21013,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
127,493005,1,1,,85148639,21013,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
128,493008,1,1,,85148639,21013,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
129,493008,1,1,,85148639,21013,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
130,493008,1,1,,85148639,21013,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
131,493008,1,1,,85148639,21013,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
132,493087,1,1,,85148639,21013,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
133,493091,1,1,,85148639,21013,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
134,493098,1,1,,85148639,21013,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
135,493131,1,1,,85148639,21013,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
136,493160,1,1,,85148639,21013,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
137,493187,1,2,,85148639,21013,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
138,493244,1,1,,85148639,21013,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
139,493244,1,1,,85148639,21013,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
140,493244,1,1,,85148639,21013,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
141,493244,1,1,,85148639,21013,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
142,504326,1,2,,85148639,21013,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
143,504326,1,2,,85148639,21013,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
144,504329,1,1,,85148639,21013,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
145,504339,1,1,,85148639,21013,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
146,504357,1,1,,85148639,21013,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
147,504357,1,1,,85148639,21013,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
148,504411,1,1,,85148639,21013,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
149,504414,1,1,,85148639,21013,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
150,504414,1,1,,85148639,21013,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
151,504423,1,1,,85148639,21013,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
152,504441,1,1,,85148639,21013,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
153,504444,1,1,,85148639,21013,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
154,504454,1,3,,85148639,21013,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
155,504462,1,1,,85148639,21013,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
156,504490,1,2,,85148639,21013,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
157,504523,1,1,,85148639,21013,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
158,504523,1,1,,85148639,21013,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
159,504558,1,1,,85148639,21013,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
160,504577,2,2,,85148639,21013,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
161,504582,2,1,,85148639,21013,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
162,504621,1,1,,85148639,21013,Active,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
163,504634,1,1,,85148639,21013,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
164,504648,1,1,,85148639,21013,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
165,504690,1,3,,85148639,21013,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
166,504692,2,2,,85148639,21013,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
167,504700,1,1,,85148639,21013,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
168,504700,1,1,,85148639,21013,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
169,504707,1,1,,85148639,21013,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
170,504707,1,1,,85148639,21013,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
171,504720,1,1,,85148639,21013,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
172,504734,1,1,,85148639,21013,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
173,504766,2,1,,85148639,21013,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
174,504775,1,1,,85148639,21013,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
175,504803,1,1,,85148639,21013,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
176,504845,1,1,,85148639,21013,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
177,504847,1,1,,85148639,21013,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
178,504884,1,2,,85148639,21013,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
179,504891,1,1,,85148639,21013,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
180,504894,1,1,,85148639,21013,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
181,504937,1,2,,85148639,21013,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
182,540253,1,1,,85148639,21013,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
183,540253,1,1,,85148639,21013,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
184,540253,1,1,,85148639,21013,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
185,540256,1,2,,85148639,21013,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
186,540263,1,1,,85148639,21013,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
187,540263,1,1,,85148639,21013,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
188,540267,1,1,,85148639,21013,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
189,540268,1,1,,85148639,21013,Active,124809506.0,811999.0,1.703,AC50_uM,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
190,540270,1,1,,85148639,21013,Active,154146191.0,3320.0,2.06,AC50_uM,HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
191,540276,1,2,,85148639,21013,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
192,540295,1,1,,85148639,21013,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
193,540303,1,1,,85148639,21013,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
194,540303,1,1,,85148639,21013,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
195,540303,1,1,,85148639,21013,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
196,540308,1,1,,85148639,21013,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
197,540317,1,1,,85148639,21013,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
198,540336,1,1,,85148639,21013,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
199,540336,1,1,,85148639,21013,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
200,540364,1,2,,85148639,21013,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
201,588334,1,1,,85148639,21013,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
202,588335,1,1,,85148639,21013,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
203,588352,1,2,,85148639,21013,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
204,588354,1,1,,85148639,21013,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
205,588358,1,2,,85148639,21013,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
206,588391,1,1,,85148639,21013,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
207,588405,1,1,,85148639,21013,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
208,588413,1,2,,85148639,21013,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
209,588436,1,1,,85148639,21013,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
210,588453,1,1,,85148639,21013,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
211,588456,1,1,,85148639,21013,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
212,588458,1,1,,85148639,21013,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
213,588473,1,1,,85148639,21013,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
214,588473,1,1,,85148639,21013,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
215,588475,1,2,,85148639,21013,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
216,588475,1,2,,85148639,21013,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
217,588489,1,1,,85148639,21013,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
218,588492,1,1,,85148639,21013,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
219,588493,1,2,,85148639,21013,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
220,588497,1,2,,85148639,21013,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
221,588497,1,2,,85148639,21013,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
222,588497,1,2,,85148639,21013,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
223,588499,1,3,,85148639,21013,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
224,588499,1,3,,85148639,21013,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
225,588499,1,3,,85148639,21013,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
226,588501,1,2,,85148639,21013,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
227,588501,1,2,,85148639,21013,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
228,588501,1,2,,85148639,21013,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
229,588513,1,1,,17389556,21013,Inconclusive,348019627.0,2099.0,28.1838,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
230,588514,1,1,,17389556,21013,Inconclusive,348019627.0,2099.0,15.8489,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
231,588515,1,1,,17389556,21013,Inconclusive,124375976.0,367.0,7.9433,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
232,588516,1,1,,17389556,21013,Inconclusive,124375976.0,367.0,19.9526,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
233,588526,1,1,,17389556,21013,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
234,588527,1,1,,17389556,21013,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
235,588532,1,1,,17389556,21013,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
236,588533,1,1,,17389556,21013,Inconclusive,311348376.0,2908.0,17.7828,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
237,588534,1,1,,17389556,21013,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
238,588535,1,1,,17389556,21013,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
239,588536,1,1,,17389556,21013,Inconclusive,216409692.0,5468.0,5.6234,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
240,588537,1,1,,17389556,21013,Inconclusive,216409692.0,5468.0,35.4813,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
241,588541,1,1,,17389556,21013,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
242,588543,1,1,,17389556,21013,Inconclusive,216409708.0,7421.0,25.1189,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
243,588544,1,1,,17389556,21013,Inconclusive,325495497.0,6256.0,28.1838,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
244,588545,1,1,,17389556,21013,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
245,588546,1,1,,17389556,21013,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
246,588547,1,1,,17389556,21013,Inconclusive,189491771.0,7068.0,44.6684,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
247,588549,1,1,,85148639,21013,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
248,588579,1,1,,85148639,21013,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
249,588590,1,1,,85148639,21013,Inconclusive,154350220.0,11201.0,50.1187,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
250,588591,1,1,,85148639,21013,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
251,588621,1,1,,85148639,21013,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
252,588664,1,2,,85148639,21013,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
253,588664,1,2,,85148639,21013,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
254,588674,1,2,,85148639,21013,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
255,588689,1,1,,85148639,21013,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
256,588692,2,1,,85148639,21013,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
257,588726,1,2,,85148639,21013,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
258,588727,1,1,,85148639,21013,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
259,588795,1,1,,85148639,21013,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
260,588812,1,1,,17389556,21013,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
261,588812,1,1,1.0,17389556,21013,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
262,588812,1,1,2.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
263,588812,1,1,3.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
264,588812,1,1,4.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
265,588812,1,1,5.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
266,588812,1,1,6.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
267,588812,1,1,7.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
268,588812,1,1,8.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
269,588812,1,1,9.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
270,588812,1,1,10.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
271,588812,1,1,11.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
272,588812,1,1,12.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
273,588812,1,1,13.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
274,588812,1,1,14.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
275,588812,1,1,15.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
276,588812,1,1,16.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
277,588812,1,1,17.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
278,588812,1,1,18.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
279,588812,1,1,19.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
280,588812,1,1,20.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
281,588812,1,1,21.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
282,588812,1,1,22.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
283,588812,1,1,23.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
284,588812,1,1,24.0,17389556,21013,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
285,588812,1,1,25.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
286,588812,1,1,26.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
287,588812,1,1,27.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
288,588812,1,1,28.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
289,588812,1,1,29.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
290,588812,1,1,30.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
291,588812,1,1,31.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
292,588812,1,1,32.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
293,588812,1,1,33.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
294,588812,1,1,34.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
295,588812,1,1,35.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
296,588812,1,1,36.0,17389556,21013,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
297,588812,1,1,37.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
298,588812,1,1,38.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
299,588812,1,1,39.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
300,588812,1,1,40.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
301,588812,1,1,41.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
302,588812,1,1,42.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
303,588812,1,1,43.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
304,588812,1,1,44.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
305,588812,1,1,45.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
306,588812,1,1,46.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
307,588812,1,1,47.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
308,588812,1,1,48.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
309,588812,1,1,49.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
310,588812,1,1,50.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
311,588812,1,1,51.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
312,588812,1,1,52.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
313,588812,1,1,53.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
314,588812,1,1,54.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
315,588812,1,1,55.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
316,588812,1,1,56.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
317,588812,1,1,57.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
318,588812,1,1,58.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
319,588812,1,1,59.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
320,588812,1,1,60.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
321,588812,1,1,61.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
322,588812,1,1,62.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
323,588812,1,1,63.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
324,588812,1,1,64.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
325,588812,1,1,65.0,17389556,21013,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
326,588812,1,1,66.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
327,588812,1,1,67.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
328,588812,1,1,68.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
329,588812,1,1,69.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
330,588812,1,1,70.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
331,588812,1,1,71.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
332,588812,1,1,72.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
333,588812,1,1,73.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
334,588812,1,1,74.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
335,588812,1,1,75.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
336,588812,1,1,76.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
337,588812,1,1,77.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
338,588812,1,1,78.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
339,588812,1,1,79.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
340,588812,1,1,80.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
341,588812,1,1,81.0,17389556,21013,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
342,588813,1,1,,17389556,21013,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
343,588813,1,1,1.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
344,588813,1,1,2.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
345,588813,1,1,3.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
346,588813,1,1,4.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
347,588813,1,1,5.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
348,588813,1,1,6.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
349,588813,1,1,7.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
350,588813,1,1,8.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
351,588813,1,1,9.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
352,588813,1,1,10.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
353,588813,1,1,11.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
354,588813,1,1,12.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
355,588813,1,1,13.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
356,588813,1,1,14.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
357,588813,1,1,15.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
358,588813,1,1,16.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
359,588813,1,1,17.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
360,588813,1,1,18.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
361,588813,1,1,19.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
362,588813,1,1,20.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
363,588813,1,1,21.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
364,588813,1,1,22.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
365,588813,1,1,23.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
366,588813,1,1,24.0,17389556,21013,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
367,588813,1,1,25.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
368,588813,1,1,26.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
369,588813,1,1,27.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
370,588813,1,1,28.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
371,588813,1,1,29.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
372,588813,1,1,30.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
373,588813,1,1,31.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
374,588813,1,1,32.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
375,588813,1,1,33.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
376,588813,1,1,34.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
377,588813,1,1,35.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
378,588813,1,1,36.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
379,588813,1,1,37.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
380,588813,1,1,38.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
381,588813,1,1,39.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
382,588813,1,1,40.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
383,588813,1,1,41.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
384,588813,1,1,42.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
385,588813,1,1,43.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
386,588813,1,1,44.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
387,588813,1,1,45.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
388,588813,1,1,46.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
389,588813,1,1,47.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
390,588813,1,1,48.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
391,588813,1,1,49.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
392,588813,1,1,50.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
393,588813,1,1,51.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
394,588813,1,1,52.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
395,588813,1,1,53.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
396,588813,1,1,54.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
397,588813,1,1,55.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
398,588813,1,1,56.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
399,588813,1,1,57.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
400,588813,1,1,58.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
401,588813,1,1,59.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
402,588813,1,1,60.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
403,588813,1,1,61.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
404,588813,1,1,62.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
405,588813,1,1,63.0,17389556,21013,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
406,588813,1,1,64.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
407,588813,1,1,65.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
408,588813,1,1,66.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
409,588813,1,1,67.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
410,588813,1,1,68.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
411,588813,1,1,69.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
412,588813,1,1,70.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
413,588813,1,1,71.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
414,588813,1,1,72.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
415,588813,1,1,73.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
416,588813,1,1,74.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
417,588813,1,1,75.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
418,588813,1,1,76.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
419,588813,1,1,77.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
420,588813,1,1,78.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
421,588813,1,1,79.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
422,588813,1,1,80.0,17389556,21013,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
423,588813,1,1,81.0,17389556,21013,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
424,588814,1,3,,85148639,21013,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
425,588819,1,4,,85148639,21013,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
426,588834,2,1,,17389556,21013,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
427,588850,1,1,,85148639,21013,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
428,588852,1,3,,85148639,21013,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
429,588855,1,1,,85148639,21013,Inconclusive,18418623.0,4088.0,7.0795,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
430,588856,1,1,,85148639,21013,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
431,602123,1,1,,85148639,21013,Active,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
432,602141,1,1,,85148639,21013,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
433,602162,1,1,,85148639,21013,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
434,602163,1,1,,85148639,21013,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
435,602179,1,2,,85148639,21013,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
436,602229,1,1,,85148639,21013,Active,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
437,602230,1,1,,85148639,21013,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
438,602233,1,1,,85148639,21013,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
439,602244,1,2,,85148639,21013,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
440,602247,1,2,,85148639,21013,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
441,602248,1,2,,85148639,21013,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
442,602250,1,2,,85148639,21013,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
443,602261,1,1,,85148639,21013,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
444,602274,1,2,,85148639,21013,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
445,602281,1,1,,85148639,21013,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
446,602281,1,1,,85148639,21013,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
447,602310,1,2,,85148639,21013,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
448,602313,1,1,,85148639,21013,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
449,602329,1,1,,85148639,21013,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
450,602332,1,1,,85148639,21013,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
451,602340,1,2,,85148639,21013,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
452,602342,2,1,,85148639,21013,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
453,602346,1,1,,85148639,21013,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
454,602363,1,1,,85148639,21013,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
455,602393,1,1,,85148639,21013,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
456,602396,1,2,,85148639,21013,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
457,602399,1,2,,85148639,21013,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
458,602405,1,1,,85148639,21013,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
459,602410,1,1,,85148639,21013,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
460,602429,1,1,,85148639,21013,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
461,602438,1,1,,85148639,21013,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
462,602440,1,1,,85148639,21013,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
463,602449,1,2,,85148639,21013,Active,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
464,602481,1,1,,85148639,21013,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
465,623870,1,1,,85148639,21013,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
466,623870,1,1,,85148639,21013,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
467,623901,1,1,,85148639,21013,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
468,624037,1,3,,85148639,21013,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
469,624038,1,3,,85148639,21013,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
470,624040,1,3,,85148639,21013,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
471,624125,1,4,,85148639,21013,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
472,624126,1,3,,85148639,21013,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
473,624127,1,2,,85148639,21013,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
474,624168,1,1,,85148639,21013,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
475,624169,1,1,,85148639,21013,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
476,624170,1,1,,85148639,21013,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
477,624171,1,1,,85148639,21013,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
478,624172,1,1,,85148639,21013,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
479,624173,1,3,,85148639,21013,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
480,624178,1,1,,85148639,21013,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
481,624202,1,1,,85148639,21013,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
482,624204,1,2,,85148639,21013,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
483,624246,1,1,,85148639,21013,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
484,624256,1,2,,85148639,21013,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
485,624263,1,1,,85148639,21013,Inconclusive,3063388.0,5071.0,14.1254,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
486,624263,1,1,,85148639,21013,Inconclusive,37183032.0,,14.1254,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
487,624267,1,2,,85148639,21013,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
488,624267,1,2,,85148639,21013,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
489,624268,1,3,,85148639,21013,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
490,624287,1,1,,85148639,21013,Inactive,52000961.0,2778.0,,Potency,"qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
491,624288,1,1,,85148639,21013,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
492,624291,1,1,,85148639,21013,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
493,624296,1,1,,85148639,21013,Active,7705682.0,51053.0,14.581,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
494,624297,1,1,,85148639,21013,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
495,624304,1,2,,85148639,21013,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
496,624330,1,2,,85148639,21013,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
497,624352,1,1,,85148639,21013,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
498,624354,1,1,,85148639,21013,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
499,624377,1,1,,85148639,21013,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
500,624378,1,1,,85148639,21013,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
501,624379,1,1,,85148639,21013,Active,9629429.0,,,,"Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16)",Screening,,
502,624414,1,1,,85148639,21013,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
503,624415,1,2,,85148639,21013,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
504,624416,1,1,,85148639,21013,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
505,624417,1,1,,85148639,21013,Inconclusive,1724069.0,2740.0,7.9433,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
506,624418,1,1,,85148639,21013,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
507,624463,1,1,,85148639,21013,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
508,624464,1,1,,85148639,21013,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
509,624465,1,1,,85148639,21013,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
510,624466,1,3,,85148639,21013,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
511,624467,1,1,,85148639,21013,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
512,624483,1,1,,85148639,21013,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
513,624504,1,1,,85148639,21013,Active,,,,,Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay,Screening,,
514,651550,1,1,,85148639,21013,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
515,651560,1,1,,85148639,21013,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
516,651572,1,2,,85148639,21013,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
517,651582,1,1,,85148639,21013,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
518,651602,1,1,,85148639,21013,Active,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
519,651602,1,1,,85148639,21013,Active,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
520,651602,1,1,,85148639,21013,Active,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
521,651631,4,1,,144207303,21013,Inconclusive,269849759.0,7157.0,5.3211,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
522,651632,4,1,,144207303,21013,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
523,651633,4,1,,144207303,21013,Inconclusive,,,21.1836,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
524,651634,4,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
525,651635,1,3,,85148639,21013,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
526,651636,1,1,,85148639,21013,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
527,651640,1,1,,85148639,21013,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
528,651644,1,1,,85148639,21013,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
529,651647,1,1,,85148639,21013,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
530,651654,1,1,,85148639,21013,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
531,651658,1,1,,85148639,21013,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
532,651661,2,1,,85148639,21013,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
533,651687,1,1,,85148639,21013,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
534,651699,1,1,,85148639,21013,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
535,651699,1,1,,85148639,21013,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
536,651702,1,2,,85148639,21013,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
537,651704,2,1,,85148639,21013,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
538,651710,1,1,,85148639,21013,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
539,651711,2,1,,85148639,21013,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
540,651718,1,2,,85148639,21013,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
541,651719,1,2,,85148639,21013,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
542,651723,1,1,,85148639,21013,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
543,651724,1,1,,85148639,21013,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
544,651725,1,1,,85148639,21013,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
545,651741,1,1,,17389556,21013,Active,20149576.0,4780.0,11.8832,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
546,651743,1,1,,17389556,21013,Active,269849759.0,7157.0,39.8107,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
547,651749,1,1,,17389556,21013,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
548,651751,1,1,,17389556,21013,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
549,651754,1,1,,17389556,21013,Active,,,42.1632,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
550,651755,1,1,,17389556,21013,Active,,,42.1632,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
551,651757,1,1,,17389556,21013,Inconclusive,25952111.0,7124.0,74.97800000000001,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
552,651758,1,1,,17389556,21013,Inconclusive,186368.0,3576.0,74.97800000000001,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
553,651768,1,2,,85148639,21013,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
554,651777,1,1,,17389556,21013,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
555,651778,1,1,,17389556,21013,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
556,651800,1,1,,85148639,21013,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
557,651802,1,1,,17389556,21013,Active,49066040.0,6097.0,23.7101,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
558,651819,1,1,,85148639,21013,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
559,651820,1,1,,85148639,21013,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
560,651821,2,4,,85148639,21013,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
561,651838,1,1,,17389556,21013,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
562,651838,1,1,1.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
563,651838,1,1,2.0,17389556,21013,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
564,651838,1,1,3.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
565,651838,1,1,4.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
566,651838,1,1,5.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
567,651838,1,1,6.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
568,651838,1,1,7.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
569,651838,1,1,8.0,17389556,21013,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
570,651957,1,1,,85148639,21013,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
571,651958,1,1,,85148639,21013,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
572,651982,1,1,,85148639,21013,Active,16130723.0,947287.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
573,651982,1,1,,85148639,21013,Active,16130724.0,947286.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
574,651982,1,1,,85148639,21013,Active,16130726.0,947294.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
575,651983,1,1,,85148639,21013,Inactive,,,,,Counterscreen for inhibitors of RecBCD: Absorbance-based cell-based high throughput assay to identify inhibitors of bacterial viability,Screening,,
576,651984,1,1,,85148639,21013,Inactive,15645703.0,899625.0,,,Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex,Screening,,
577,651984,1,1,,85148639,21013,Inactive,15646160.0,899738.0,,,Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex,Screening,,
578,651999,1,1,,85148639,21013,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
579,652010,1,1,,85148639,21013,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
580,652017,1,1,,85148639,21013,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
581,652025,1,1,,85148639,21013,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
582,652039,1,1,,85148639,21013,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
583,652048,1,2,,85148639,21013,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
584,652051,1,1,,85148639,21013,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
585,652054,1,1,,85148639,21013,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
586,652067,1,4,,85148639,21013,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
587,652104,1,1,,85148639,21013,Inconclusive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
588,652105,1,1,,85148639,21013,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
589,652106,1,1,,85148639,21013,Inactive,586067.0,6622.0,7.0795,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
590,652115,1,1,,85148639,21013,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
591,652126,1,3,,85148639,21013,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
592,652150,1,1,,85148639,21013,Inactive,,,82.24,IC50,Counterscreen for inhibitors of RecBCD: Absorbance-based cell-based high throughput dose response assay to identify inhibitors of bacterial viability,Confirmatory,,
593,652151,1,1,,85148639,21013,Inactive,16130723.0,947287.0,63.537,IC50,Absorbance-based bacterial cell-based high throughput dose response assay to identify inhibitors of RecBCD,Confirmatory,,
594,652151,1,1,,85148639,21013,Inactive,16130724.0,947286.0,63.537,IC50,Absorbance-based bacterial cell-based high throughput dose response assay to identify inhibitors of RecBCD,Confirmatory,,
595,652151,1,1,,85148639,21013,Inactive,16130726.0,947294.0,63.537,IC50,Absorbance-based bacterial cell-based high throughput dose response assay to identify inhibitors of RecBCD,Confirmatory,,
596,652154,1,1,,85148639,21013,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
597,652162,2,1,,85148639,21013,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
598,652163,1,1,,85148639,21013,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
599,652197,1,1,,85148639,21013,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
600,652257,1,1,,85148639,21013,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
601,686940,1,1,,85148639,21013,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
602,686964,1,1,,85148639,21013,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
603,686970,1,2,,85148639,21013,Active,49168486.0,3417.0,25.929000000000002,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
604,686971,1,2,,85148639,21013,Active,,,20.5962,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
605,686978,1,1,,85148639,21013,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
606,686979,1,1,,85148639,21013,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
607,686992,2,1,,85148639,21013,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
608,686996,1,1,,85148639,21013,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
609,687014,1,1,,85148639,21013,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
610,687016,1,1,,85148639,21013,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
611,720504,1,1,,85148639,21013,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
612,720508,1,1,,85148639,21013,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
613,720509,1,1,,85148639,21013,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
614,720511,1,1,,85148639,21013,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
615,720516,2,1,,144207303,21013,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
616,720542,1,2,,85148639,21013,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
617,720543,1,1,,85148639,21013,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
618,720551,1,2,,85148639,21013,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
619,720552,2,1,,144207303,21013,Inconclusive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
620,720553,1,2,,85148639,21013,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
621,720579,2,1,,85148639,21013,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
622,720580,1,1,,85148639,21013,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
623,720582,1,1,,85148639,21013,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
624,720596,1,1,,85148639,21013,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
625,720634,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
626,720635,2,1,,144207303,21013,Active,,,3.767,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
627,720636,1,1,,17389556,21013,Inactive,20149576.0,4780.0,18.8336,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
628,720637,2,1,,144207303,21013,Active,,,4.92795,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
629,720647,1,2,,85148639,21013,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
630,720648,1,1,,85148639,21013,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
631,720652,1,1,,17389556,21013,Inconclusive,,,42.1632,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
632,720653,1,1,,17389556,21013,Inconclusive,,,39.8107,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
633,720659,1,1,,17389556,21013,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
634,720674,2,2,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
635,720675,2,2,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
636,720678,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
637,720679,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
638,720680,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
639,720681,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
640,720682,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
641,720683,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
642,720684,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
643,720685,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
644,720686,2,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
645,720687,2,2,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
646,720691,4,1,,144207303,21013,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
647,720692,3,1,,144207303,21013,Inconclusive,311348376.0,2908.0,19.0439,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
648,720693,3,1,,144207303,21013,Active,,,21.3676,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
649,720700,1,4,,85148639,21013,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
650,720702,1,1,,85148639,21013,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
651,720704,1,4,,85148639,21013,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
652,720706,1,2,,85148639,21013,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
653,720707,1,2,,85148639,21013,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
654,720708,1,2,,85148639,21013,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
655,720709,1,2,,85148639,21013,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
656,720711,1,2,,85148639,21013,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
657,720719,2,1,,144207303,21013,Inconclusive,311348376.0,2908.0,21.3676,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
658,720725,2,1,,144207303,21013,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
659,743012,3,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
660,743014,3,1,,144207303,21013,Inconclusive,,,75.1623,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
661,743015,3,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
662,743033,3,1,,144207303,21013,Active,,,53.673,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
663,743035,2,1,,144207303,21013,Inconclusive,124375976.0,367.0,3.3865,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
664,743036,2,1,,144207303,21013,Inconclusive,124375976.0,367.0,16.9729,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
665,743040,3,1,,144207303,21013,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
666,743041,3,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
667,743042,3,1,,144207303,21013,Active,124375976.0,367.0,59.7035,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
668,743053,2,1,,144207303,21013,Inconclusive,124375976.0,367.0,14.2809,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
669,743054,2,1,,144207303,21013,Inconclusive,124375976.0,367.0,59.7035,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
670,743063,2,1,,144207303,21013,Inconclusive,124375976.0,367.0,39.4841,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
671,743064,3,1,,144207303,21013,Active,,,29.9226,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
672,743065,3,1,,144207303,21013,Active,399498506.0,24831.0,14.9968,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
673,743066,3,1,,144207303,21013,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
674,743067,2,1,,144207303,21013,Inconclusive,399498506.0,24831.0,11.9124,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
675,743069,2,1,,144207303,21013,Inconclusive,348019627.0,2099.0,7.5815,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
676,743074,2,1,,144207303,21013,Inconclusive,,,3.0183,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
677,743075,2,1,,144207303,21013,Inactive,348019627.0,2099.0,60.2221,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
678,743077,2,1,,144207303,21013,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
679,743078,2,1,,144207303,21013,Inconclusive,348019627.0,2099.0,9.54456,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
680,743079,3,1,,144207303,21013,Inconclusive,348019627.0,2099.0,59.7035,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
681,743080,3,1,,144207303,21013,Inconclusive,348019627.0,2099.0,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
682,743081,3,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
683,743083,3,1,,144207303,21013,Inconclusive,119597822.0,1588.0,66.9885,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
684,743084,3,1,,144207303,21013,Inconclusive,,,75.1623,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
685,743085,3,1,,144207303,21013,Active,51095037.0,196.0,11.9124,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
686,743086,3,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
687,743091,2,1,,144207303,21013,Inconclusive,348019627.0,2099.0,66.9885,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
688,743094,3,1,,144207303,21013,Inconclusive,216409692.0,5468.0,21.3676,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
689,743122,2,1,,144207303,21013,Active,51095037.0,196.0,11.4639,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
690,743126,1,1,,85148639,21013,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
691,743139,2,1,,144207303,21013,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
692,743140,2,1,,144207303,21013,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
693,743191,3,1,,144207303,21013,Inconclusive,216409692.0,5468.0,23.9749,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
694,743194,3,1,,144207303,21013,Inconclusive,,,1.2016,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
695,743199,2,1,,144207303,21013,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
696,743202,4,1,,144207303,21013,Inconclusive,20149576.0,4780.0,16.8267,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
697,743203,3,1,,144207303,21013,Inconclusive,,,4.7424,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
698,743209,3,1,,144207303,21013,Active,,,13.482000000000001,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
699,743210,4,1,,144207303,21013,Inconclusive,4504517.0,3315.0,19.0439,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
700,743211,3,1,,144207303,21013,Inconclusive,,,16.9729,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
701,743212,3,1,,144207303,21013,Inconclusive,216409690.0,5467.0,60.2221,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
702,743213,3,1,,144207303,21013,Inconclusive,,,53.673,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
703,743215,3,1,,144207303,21013,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
704,743217,3,1,,144207303,21013,Inconclusive,325495553.0,9971.0,53.673,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
705,743218,3,1,,144207303,21013,Active,,,47.8361,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
706,743219,3,1,,144207303,21013,Inconclusive,20149576.0,4780.0,4.74242,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
707,743220,3,1,,144207303,21013,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
708,743221,3,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
709,743222,3,1,,144207303,21013,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
710,743223,3,1,,144207303,21013,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
711,743224,3,1,,144207303,21013,Active,,,23.9749,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
712,743225,3,1,,144207303,21013,Inconclusive,,,3.0183,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
713,743226,2,1,,144207303,21013,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
714,743227,2,1,,144207303,21013,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
715,743228,3,1,,144207303,21013,Active,4504517.0,3315.0,49.7076,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
716,743238,1,1,,85148639,21013,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
717,743239,2,1,,144207303,21013,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
718,743240,2,1,,144207303,21013,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
719,743241,2,1,,144207303,21013,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
720,743242,2,1,,144207303,21013,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
721,743247,1,2,,85148639,21013,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
722,743255,1,1,,85148639,21013,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
723,743266,1,2,,85148639,21013,Inactive,296080761.0,5745.0,79.4328,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
724,743269,1,1,,85148639,21013,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
725,743269,1,1,,85148639,21013,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
726,743279,1,2,,85148639,21013,Inconclusive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
727,743288,1,1,,17389556,21013,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
728,743292,1,1,,17389556,21013,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
729,743397,1,1,,85148639,21013,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
730,743398,1,1,,85148639,21013,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
731,743445,1,1,,85148639,21013,Inactive,109633019.0,7468.0,,,"Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_SinglePoint_HTS_Activity_Set2",Screening,,
732,1053197,1,1,,85148639,21013,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
733,1159509,1,1,,144207303,21013,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
734,1159515,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
735,1159516,1,1,,144207303,21013,Inconclusive,119611100.0,22926.0,60.2221,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
736,1159517,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
737,1159518,1,1,,144207303,21013,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
738,1159519,1,1,,144207303,21013,Inconclusive,119611100.0,22926.0,50.6706,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
739,1159520,1,1,,144207303,21013,Active,,,53.2108,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
740,1159521,1,1,,144207303,21013,Active,15928672.0,19885.0,23.7684,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
741,1159523,1,1,,144207303,21013,Inconclusive,15928672.0,19885.0,24.6983,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
742,1159524,1,1,,85148639,21013,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
743,1159525,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
744,1159526,1,1,,144207303,21013,Inconclusive,119627033.0,3725.0,37.9976,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
745,1159527,1,1,,144207303,21013,Inconclusive,325495497.0,6256.0,8.5066,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
746,1159528,1,1,,144207303,21013,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
747,1159529,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
748,1159531,1,1,,144207303,21013,Inconclusive,325495497.0,6256.0,11.1281,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
749,1159551,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
750,1159552,1,1,,144207303,21013,Active,325495463.0,5914.0,53.2108,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
751,1159553,2,1,,144207303,21013,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
752,1159555,1,1,,144207303,21013,Inconclusive,325495463.0,5914.0,47.4242,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
753,1159606,1,1,,85148639,21013,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
754,1224834,3,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
755,1224835,1,1,,144207303,21013,Inconclusive,160794.0,,87.3212,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
756,1224836,1,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
757,1224837,1,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
758,1224838,1,1,,144207303,21013,Inconclusive,66775687.0,9970.0,75.1623,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
759,1224839,1,1,,144207303,21013,Inconclusive,66775687.0,9970.0,23.7684,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
760,1224840,3,1,,144207303,21013,Inconclusive,,,53.2108,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
761,1224841,3,1,,144207303,21013,Active,325495545.0,2101.0,21.1836,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
762,1224842,3,1,,144207303,21013,Inactive,325495545.0,2101.0,23.7684,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
763,1224843,1,1,,144207303,21013,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
764,1224844,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
765,1224845,1,1,,144207303,21013,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
766,1224846,1,1,,144207303,21013,Inconclusive,11995455.0,3091.0,26.9002,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
767,1224847,1,1,,144207303,21013,Active,,,49.3104,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
768,1224848,3,1,,144207303,21013,Active,325495545.0,2101.0,26.6686,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
769,1224849,3,1,,144207303,21013,Inactive,325495545.0,2101.0,26.6686,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
770,1224865,1,2,,85148639,21013,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
771,1224867,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
772,1224868,1,1,,144207303,21013,Active,,,47.8361,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
773,1224869,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
774,1224870,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
775,1224871,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
776,1224872,1,1,,144207303,21013,Inconclusive,,,53.673,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
777,1224873,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
778,1224874,1,1,,144207303,21013,Active,,,47.8361,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
779,1224875,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
780,1224876,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
781,1224877,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
782,1224878,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
783,1224879,1,1,,144207303,21013,Inconclusive,,,60.2221,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
784,1224880,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
785,1224881,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
786,1224882,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
787,1224883,1,1,,144207303,21013,Inconclusive,,,60.2221,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
788,1224884,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
789,1224885,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
790,1224886,1,1,,144207303,21013,Active,,,47.8361,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
791,1224887,1,1,,144207303,21013,Inconclusive,,,53.673,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
792,1224888,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
793,1224889,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
794,1224890,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
795,1224892,1,1,,144207303,21013,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
796,1224893,1,1,,144207303,21013,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
797,1224894,1,1,,144207303,21013,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
798,1224895,1,1,,144207303,21013,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
799,1224896,1,1,,144207303,21013,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
800,1259241,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
801,1259242,1,1,,144207303,21013,Inconclusive,,,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
802,1259243,1,1,,144207303,21013,Inconclusive,124375976.0,367.0,66.9885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
803,1259244,1,1,,144207303,21013,Active,348019627.0,2099.0,29.9226,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
804,1259247,1,1,,144207303,21013,Inconclusive,124375976.0,367.0,59.7035,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
805,1259248,1,1,,144207303,21013,Active,348019627.0,2099.0,25.6645,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
806,1259313,1,1,,85148639,21013,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
807,1259318,1,1,,85148639,21013,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
808,1259364,1,1,,144207303,21013,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
809,1259365,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
810,1259366,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
811,1259367,1,1,,144207303,21013,Inconclusive,,,59.7035,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
812,1259368,1,1,,144207303,21013,Inactive,109731339.0,2737.0,29.9226,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
813,1259369,1,1,,144207303,21013,Active,109731339.0,2737.0,26.6686,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
814,1259377,1,1,,144207303,21013,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
815,1259378,1,1,,144207303,21013,Active,54288833.0,2100.0,13.366,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
816,1259379,1,1,,144207303,21013,Active,,,59.7035,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
817,1259380,1,1,,144207303,21013,Inconclusive,,,14.9968,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
818,1259381,1,1,,144207303,21013,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
819,1259382,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
820,1259383,1,1,,144207303,21013,Inactive,348019627.0,2099.0,59.7035,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
821,1259384,1,1,,144207303,21013,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
822,1259385,1,1,,144207303,21013,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
823,1259386,1,1,,144207303,21013,Inconclusive,,,42.2669,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
824,1259387,1,1,,144207303,21013,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
825,1259388,1,1,,144207303,21013,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
826,1259390,1,1,,144207303,21013,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
827,1259391,1,1,,144207303,21013,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
828,1259392,1,1,,144207303,21013,Inconclusive,109731339.0,2737.0,33.5738,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
829,1259393,1,1,,144207303,21013,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
830,1259394,1,1,,144207303,21013,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
831,1259395,1,1,,144207303,21013,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
832,1259396,1,1,,144207303,21013,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
833,1259400,1,1,,85148639,21013,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
834,1259401,1,1,,144207303,21013,Inconclusive,325495545.0,2101.0,25.1768,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
835,1259402,1,1,,144207303,21013,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
836,1259403,1,1,,144207303,21013,Inconclusive,325495545.0,2101.0,33.5738,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
837,1259404,1,1,,144207303,21013,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
838,1259407,1,1,,363902672,21013,Inactive,,,,,CCRIS mutagenicity studies,Other,,
839,1259415,1,1,,85148639,21013,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
